New Jersey Administrative Code
Title 10 - HUMAN SERVICES
Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES
Subchapter 11 - OPIOID TREATMENT SERVICES
Section 10:161B-11.11 - Labeling of take-home medication

Universal Citation: NJ Admin Code 10:161B-11.11

Current through Register Vol. 56, No. 18, September 16, 2024

(a) Take-home medication provided to eligible clients shall be provided in a child-proof container in accordance with the Poison Prevention Packaging Act ( PL 91-601, 15 U.S.C. 1471, Federal Consumer Product Safety Commission, http://www.cpsc.gov//Global/PDF/Statues/pppa.pdf and shall be labeled as follows:

Name, address, and telephone number of the opioid treatment program

Date of issue

Client's full name

Name and strength of drug

Number of doses, if multiple dose

Directions for use

Name of prescribing Physician or advanced practice nurse

Warning/caution statement

Disclaimer: These regulations may not be the most recent version. New Jersey may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.